FDA Approves Cell Therapy for Blood Cancer Patients

Cell therapy has the potential to reduce the risk of infection after stem cell transplants. The U.S. Food and Drug Administration (FDA) recently approved Omisirge (omidubicel-onlv), a donor-modified…

Read More
Back to top
FE3